Cornerstone Therapeutics (NASDAQ:CRTX) has announced that it will release a financial guidance for 2010 on Thursday, January 7. The guidance will be released on the company’s website, www.crtx.com. The company will hold a conference call at 8:30 am ET that morning to review the guidance.
Penny Stock Professor, a leading financial publication, is pleased to alert investors of stocks on the move. Sign Up for our Free Penny Stock Picks.
Interested parties are invited to join the call by dialing 866.271.5140, or 617.213.8893 for international callers, and enter the pass code 45969044. To listen to an audio replay, dial 888.286.8010, or 617.801.6888 for international listeners, pass code 88256043. A webcast will be archived on the company’s website for thirty days following the event.
Cornerstone Therapeutics Inc. is a specialty pharmaceutical company focused on acquiring, developing and commercializing prescription products for the respiratory market. On October 31, 2008, the Company completed the merger with Cornerstone BioPharma. The product development pipeline includes two SPECTRACEF line extensions: a once daily dosage tablet, or SPECTRACEF Once Daily, and an oral suspension for the pediatric market, or SPECTRACEF Suspension. The product development pipeline also includes three additional product candidates: an anticholinergic, or drying agent, and antihistamine combination product candidate for the treatment of symptoms of allergic rhinitis and two antitussive, or cough suppressant, and antihistamine combination product candidates. The SPECTRACEF product line includes SPECTRACEF 200 milligram and SPECTRACEF 400 milligram for the treatment of mild to moderate infections caused by pathogens associated with particular respiratory tract infections.
Follow us on Twitter: http://www.twitter.com/pennystockspro
Sign up for the free Penny Stock Professor newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website.
About Us
Penny Stock Professor is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer.
